ViroStatics is committed to expand its know how and expertise. In many cases this will include establishing mutually beneficial partnerships with organizations that have complementary strengths. Current collaborations include:
Design and renaturalization activities in technology and biotechnology area. Research & Development, Micropropagation, Native Sardinian flora, Clonal population, Dedicated Substrate.
DaXem develops and engineers antimicrobial coatings for a hygienically, safer living ambient. DaXem creates technological driven products to maintain every surface sanitized and germ-free to keep our lives healthier and safer.
Division of Microbiology and Infectious Diseases (DMID)
DMID supports extramural research to control and prevent diseases caused by virtually all human infectious agents. DMID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, preclinical development, and clinical evaluation.
Company active in industrial waste management services and remediation project. Research & Development area oriented to Circular Economy. Strong know-how, high quality and safety standards.
World class leader for 70 years in the Electronic Defense Sector through the Electromagnetic Spectrum Dominance and involved in several major European Defense Projects. Their Engineers have conceived the E4shield device, a unique technology, to inactivate airborne viruses in close spaces.
Laboratory of Materials Science and Nanotechnology Department of Biomedical Sciences
The Laboratory, which belongs to University of Sassari, is directed by Prof. Plinio Innocenzi and is dedicated to sol-gel science, nanoscience and nanotechnology, with a special focus on self-assembly phenomena.
Active in complementary areas of technology: biomarker discovery, diagnostic systems and biotechnologies in nutrition and health.
Promote research and technology transfer and the development of a knowledge-based local economy.
Drug development partner, worked for Genentech, Pfizer, Bayer. Several compounds advanced to Phase 2 & 3.